Virax Biolabs Group Ltd. (VRAX)
2.83
+0.10
(+3.66%)
USD |
NASDAQ |
Sep 10, 14:58
Virax Biolabs Group Market Cap : 1.639M for Sept. 10, 2026
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Market Cap Data
| Date | Value |
|---|---|
| September 09, 2026 | 1.581M |
| September 08, 2026 | 1.523M |
| September 04, 2026 | 1.520M |
| September 03, 2026 | 1.483M |
| September 02, 2026 | 1.474M |
| September 01, 2026 | 1.506M |
| August 31, 2026 | 1.633M |
| August 28, 2026 | 1.633M |
| August 27, 2026 | 1.703M |
| August 26, 2026 | 1.604M |
| August 25, 2026 | 1.686M |
| August 24, 2026 | 1.738M |
| August 21, 2026 | 1.848M |
| August 20, 2026 | 1.998M |
| August 19, 2026 | 1.842M |
| August 18, 2026 | 1.599M |
| August 17, 2026 | 1.628M |
| August 14, 2026 | 1.656M |
| August 13, 2026 | 1.633M |
| August 12, 2026 | 1.610M |
| August 11, 2026 | 1.662M |
| August 10, 2026 | 1.668M |
| August 07, 2026 | 1.726M |
| August 06, 2026 | 1.604M |
| August 05, 2026 | 1.686M |
| Date | Value |
|---|---|
| August 04, 2026 | 1.726M |
| August 03, 2026 | 1.703M |
| July 31, 2026 | 1.518M |
| July 30, 2026 | 1.622M |
| July 29, 2026 | 1.697M |
| July 28, 2026 | 1.674M |
| July 27, 2026 | 1.796M |
| July 24, 2026 | 1.848M |
| July 23, 2026 | 1.848M |
| July 22, 2026 | 2.108M |
| July 21, 2026 | 2.247M |
| July 20, 2026 | 2.253M |
| July 17, 2026 | 2.195M |
| July 16, 2026 | 2.259M |
| July 15, 2026 | 1.998M |
| July 14, 2026 | 2.166M |
| July 13, 2026 | 2.357M |
| July 10, 2026 | 2.363M |
| July 09, 2026 | 3.684M |
| July 08, 2026 | 1.842M |
| July 07, 2026 | 1.761M |
| July 06, 2026 | 1.801M |
| July 02, 2026 | 1.813M |
| July 01, 2026 | 1.587M |
| June 30, 2026 | 1.703M |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Interpace Biosciences, Inc. | 36.01M |
| Exlites Holdings International, Inc. | 15.42M |
| Xcelerate, Inc. | 5.387M |
| Fresenius SE & Co. KGaA | 29.11B |
| Rafina Innovations, Inc. | 0.122M |
Market Cap Related Metrics
| PS Ratio | 87.83 |
| PEG Ratio | -0.0004 |
| Price | 2.83 |
| Earnings Yield | -597.6% |
| PEGY Ratio | -0.0004 |